CONSORT 2010 changes and testing blindness in RCTs

被引：132

作者：

Schulz, Kenneth F. ^{[1
]}

Altman, Douglas G. ^{[2
]}

Moher, David ^{[3
,4
]}

Fergusson, Dean ^{[3
,4
]}

机构：

[1] Family Hlth Int, Res Triangle Pk, NC 27709 USA

[2] Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England

[3] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa Methods Ctr, Ottawa, ON, Canada

[4] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada

来源：

LANCET | 2010年 / 375卷 / 9721期

关键词：

EMPIRICAL-EVIDENCE; SUCCESS; TRIALS; BIAS; EYE;

D O I：

10.1016/S0140-6736(10)60413-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1144 / 1146

页数：3

共 16 条

[1] Turning a blind eye - Testing the success of blinding and the CONSORT statement [J].

Altman, DG ;

Schulz, KF ;

Moher, D .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7448) :1135-1135

[2] Statistics Notes - Blinding in clinical trials and other studies [J].

Day, SJ ;

Altman, DG .

BRITISH MEDICAL JOURNAL, 2000, 321 (7259) :504-504

[3] Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials [J].

Fergusson, D ;

Glass, KC ;

Waring, D ;

Shapiro, S .

BRITISH MEDICAL JOURNAL, 2004, 328 (7437) :432-434

[4] Towards a proposal for assessment of blinding success in clinical trials: up-to-date review [J].

Kolahi, Jafar ;

Bang, Heejung ;

Park, Jongbae .

COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 2009, 37 (06) :477-484

[5] The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials [J].

Moher, D ;

Schulz, KF ;

Altman, DG .

LANCET, 2001, 357 (9263) :1191-1194

[6] Validity of clinical trials of antidepressants [J].

Quitkin, FM ;

Rabkin, JG ;

Gerald, J ;

Davis, JM ;

Klein, DF .

AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (03) :327-337

[7] Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't? [J].

Sackett, David L. .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2007, 36 (03) :664-665

[8] Turning a blind eye - Why we don't test for blindness at the end of our trials [J].

Sackett, DL .

BRITISH MEDICAL JOURNAL, 2004, 328 (7448) :1136-1136

[9]

Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1136/bmj.c332, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352, 10.1136/bmj.c869, 10.1186/1741-7015-8-18]

[10] The landscape and lexicon of blinding in randomized trials [J].

Schulz, KF ;

Chalmers, I ;

Altman, DG .

ANNALS OF INTERNAL MEDICINE, 2002, 136 (03) :254-259

← 1 2 →